Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cheryl Hsiang-Ling Chiu
Observed names:
C. Chiu,
Cheryl H.-L. Chiu
Institution:
The University of Texas at San Antonio Health Science Center
Observed institutions:
The University of Texas at San Antonio Health Science Center,
Taipei Veterans General Hospital,
National Yang Ming University
ORCID:
0000-0002-6946-9785
Observed ORCID:
0000-0002-6946-9785
OpenAlex ID:
A5018627312
Ex Vivo Drug Testing of Patient-Derived Lung Organoids to Predict Treatment Responses for Personalized Medicine
2023
·
Josephine A. Taverna
, Chia-Nung Hung
, et al.
·
Lung Cancer
·
36
PDF
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages
2023
·
Chia-Nung Hung
, Meizhen Chen
, et al.
·
Cell Reports
·
31
Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination
2023
·
Chih-Wei Chou
, Chia-Nung Hung
, et al.
·
Nature Communications
·
28
PDF
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Non-Small Cell Lung Cancer with G719X/L861Q/S768I Mutations
2014
·
C. Chiu
, C. Yang
, et al.
·
Annals of Oncology
·
3
P3.02-043 Clinical and Genetic Features in Lung Adenocarcinoma Without EGFR Mutation and ALK Rearrangement in Taiwan
2017
·
T. Shiao
, C. Chiang
, et al.
·
Journal of Thoracic Oncology
PDF
Combination effects of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) and individual chemotherapeutics in non-small cell lung cancer (NSCLC) cells with and without sensitizing-EGFR mutations.
2011
·
C. Tsai
, K. Chang
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
6
Citation count:
98
H-index:
3
I10-index:
3
Year
Topic
Type